Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-25-005704
Filing Date
2025-04-28
Accepted
2025-04-28 17:05:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A iova-20250428xdefa14a.htm DEFA14A 12268
2 GRAPHIC iova-20250428xdefa14a_bg001.jpg GRAPHIC 149326
3 GRAPHIC iova-20250428xdefa14a_bg002.jpg GRAPHIC 139381
  Complete submission text file 0001558370-25-005704.txt   405059
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36860 | Film No.: 25881451
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)